Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

Patients with primary malignant brain tumors manifest a variety of abnormalities in cell-mediated and humoral immunity. Diminished T cell reactivity has been shown in these patients to be linked to deficiencies in interleukin 2 (IL-2) production that cannot be overcome by exogenous IL-2. In this stu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elliott, L H, Brooks, W H, Roszman, T L
Format: Artigo
Langue:Inglês
Publié: 1990
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC296693/
https://ncbi.nlm.nih.gov/pubmed/2365829
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires